MARKET

AMRN

AMRN

Amarin
NASDAQ
1.060
-0.010
-0.93%
After Hours: 1.041 -0.02 -1.84% 19:55 03/01 EST
OPEN
1.020
PREV CLOSE
1.070
HIGH
1.060
LOW
0.9754
VOLUME
3.50M
TURNOVER
0
52 WEEK HIGH
2.170
52 WEEK LOW
0.6510
MARKET CAP
432.79M
P/E (TTM)
-8.2298
1D
5D
1M
3M
1Y
5Y
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
NASDAQ · 15h ago
Validea Kenneth Fisher Strategy Daily Upgrade Report - 3/1/2024
NASDAQ · 18h ago
Amarin Corporation Plc’s New Competition Risk – A Cause for Worry?
TipRanks · 1d ago
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Butterfly Network, Inc. Shares dipped 21.7% to $1.1588 on Thursday. The company reported mixed fourth-quarter financial results. Enveric Biosciences gained 177.1% in Thursday's mid-day session. Volcon shares rose 55.4% after surging around 39% on Wednesday.
Benzinga · 1d ago
Amarin’s Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion
TipRanks · 1d ago
Why Is Amarin Stock Trading Lower After Q4 Earnings?
Amarin Corporation Plc reported fourth-quarter 2023 revenues of $74.71 million, down 17% from $90.2 million. The company beat the consensus of $63.81 million. U.S. Sales were adversely impacted by generic availability in the United States. Amarin initiated a share repurchase program of up to $50 million.
Benzinga · 1d ago
Options Volatility and Implied Earnings Moves Today, February 29, 2024
TipRanks · 1d ago
Notable earnings before Thursday's open
Seeking Alpha · 2d ago
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation plc (ADR) stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.